Know Cancer

or
forgot password

Randomisierte Phase II Studie Zum Einsatz Von Goserelin Und Oralen Kontrazeptiva Zur Reduktion Ovarieller Toxizitäten während Zytostatischer Primärtherapie Bei Fertilen Patientinnen Mit Hodgkin Lymphom in Fortgeschrittenen Stadien


Phase 2
18 Years
40 Years
Not Enrolling
Female
Hodgkins Lymphoma

Thank you

Trial Information

Randomisierte Phase II Studie Zum Einsatz Von Goserelin Und Oralen Kontrazeptiva Zur Reduktion Ovarieller Toxizitäten während Zytostatischer Primärtherapie Bei Fertilen Patientinnen Mit Hodgkin Lymphom in Fortgeschrittenen Stadien


Inclusion Criteria:



- Advanced stage Hodgkins Lymphoma (histologically proven)

- Normal FSH-levels

- Written informed consent

Exclusion Criteria:

- Hodgkins Lymphoma as "composite lymphoma"

- Primary ovarial dysfunction

- Age > 40

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

FSH level 6 month after end of treatment

Outcome Time Frame:

6 month

Safety Issue:

No

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

PROFE

NCT ID:

NCT01014507

Start Date:

January 2004

Completion Date:

September 2009

Related Keywords:

  • Hodgkins Lymphoma
  • Hodgkin Disease
  • Lymphoma

Name

Location